192 related articles for article (PubMed ID: 35112323)
1. Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-COV-2.
Bahoosh SR; Shokoohinia Y; Eftekhari M
Daru; 2022 Jun; 30(1):245-252. PubMed ID: 35112323
[TBL] [Abstract][Full Text] [Related]
2. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
3. Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factor.
Rodrigues D; Machado MR; Alves JV; Fraga-Silva TFC; Martins RB; Campos LCB; Francisco DF; Couto AES; Bonato VLD; Arruda E; Becari C; Auxiliadora-Martins M; Louzada-Júnior P; Costa RM; Tostes RC
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H252-H263. PubMed ID: 37327001
[TBL] [Abstract][Full Text] [Related]
4. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19.
Attiq A; Yao LJ; Afzal S; Khan MA
Int Immunopharmacol; 2021 Dec; 101(Pt B):108255. PubMed ID: 34688149
[TBL] [Abstract][Full Text] [Related]
5. NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.
Kircheis R; Haasbach E; Lueftenegger D; Heyken WT; Ocker M; Planz O
Front Immunol; 2020; 11():598444. PubMed ID: 33362782
[TBL] [Abstract][Full Text] [Related]
6. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.
Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA
Inflammation; 2021 Oct; 44(5):1865-1877. PubMed ID: 33860869
[TBL] [Abstract][Full Text] [Related]
7. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
Ahmed F
Front Immunol; 2020; 11():590459. PubMed ID: 33362771
[TBL] [Abstract][Full Text] [Related]
8. Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options.
Nazerian Y; Ghasemi M; Yassaghi Y; Nazerian A; Hashemi SM
Int Immunopharmacol; 2022 Dec; 113(Pt B):109428. PubMed ID: 36379152
[TBL] [Abstract][Full Text] [Related]
9. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
[TBL] [Abstract][Full Text] [Related]
10. NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors.
Kandasamy M
Naunyn Schmiedebergs Arch Pharmacol; 2021 Mar; 394(3):561-567. PubMed ID: 33394134
[TBL] [Abstract][Full Text] [Related]
11. Nanocurcumin Potently Inhibits SARS-CoV-2 Spike Protein-Induced Cytokine Storm by Deactivation of MAPK/NF-κB Signaling in Epithelial Cells.
Sharma VK; Prateeksha ; Singh SP; Singh BN; Rao CV; Barik SK
ACS Appl Bio Mater; 2022 Feb; 5(2):483-491. PubMed ID: 35112841
[TBL] [Abstract][Full Text] [Related]
12. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
Hariharan A; Hakeem AR; Radhakrishnan S; Reddy MS; Rela M
Inflammopharmacology; 2021 Feb; 29(1):91-100. PubMed ID: 33159646
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway.
Hamad RS; Al-Kuraishy HM; Alexiou A; Papadakis M; Ahmed EA; Saad HM; Batiha GE
Cell Stress Chaperones; 2023 Nov; 28(6):657-673. PubMed ID: 37796433
[TBL] [Abstract][Full Text] [Related]
14. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.
Rossi M; Piagnerelli M; Van Meerhaeghe A; Zouaoui Boudjeltia K
Med Hypotheses; 2020 Nov; 144():110242. PubMed ID: 33254548
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID-19.
Muhammad A; Forcados GE; Sani H; Ndidi US; Adamu A; Katsayal BS; Sadiq IZ; Abubakar YS; Sulaiman I; Abubakar IB; Yusuf AP; Malami I; Ibrahim S; Abubakar MB
J Food Biochem; 2022 May; 46(5):e14079. PubMed ID: 35060145
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection.
Creeden JF; Imami AS; Eby HM; Gillman C; Becker KN; Reigle J; Andari E; Pan ZK; O'Donovan SM; McCullumsmith RE; McCullumsmith CB
Biomed Pharmacother; 2021 Jun; 138():111437. PubMed ID: 33691249
[TBL] [Abstract][Full Text] [Related]
17. How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1α.
Moasefi N; Fouladi M; Norooznezhad AH; Yarani R; Rahmani A; Mansouri K
Inflamm Res; 2021 Jul; 70(7):749-752. PubMed ID: 34173853
[TBL] [Abstract][Full Text] [Related]
18. How do deer respiratory epithelial cells weather the initial storm of SARS-CoV-2 WA1/2020 strain?
Sarlo Davila KM; Nelli RK; Phadke KS; Ruden RM; Sang Y; Bellaire BH; Gimenez-Lirola LG; Miller LC
Microbiol Spectr; 2024 Feb; 12(2):e0252423. PubMed ID: 38189329
[TBL] [Abstract][Full Text] [Related]
19. Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis.
Kamel NA; Ismail NSM; Yahia IS; Aboshanab KM
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056328
[TBL] [Abstract][Full Text] [Related]
20. Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms.
Sanghai N; Tranmer GK
Drug Discov Today; 2020 Dec; 25(12):2076-2079. PubMed ID: 32949526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
